Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prescription drug dispensations 15 years before multiple sclerosis onset: A matched cohort study, British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Phenotyping healthcare use before pediatric-onset multiple sclerosis, including by sex and age: A matched cohort study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Impact of cancer on multiple sclerosis-related healthcare and disease-modifying drug use: A multinational cohort study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Sex-related and age-related differences in healthcare use before multiple sclerosis symptom onset: a matched cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity and inclusion: A modified e-Delphi study.

Multiple sclerosis journal - experimental, translational and clinical·2026
Same author

Healthcare use before paediatric multiple sclerosis onset differs by age and sex: a nationwide cohort study.

BMJ neurology open·2026
Same journal

Ataxia Global Initiative recommend MRI end-points for clinical trials in ataxias.

Nature reviews. Neurology·2026
Same journal

Adaptive deep brain stimulation in Parkinson disease: clinical implementation and outlook.

Nature reviews. Neurology·2026
Same journal

Moving artificial intelligence from research to real-world clinical use in neurology.

Nature reviews. Neurology·2026
Same journal

Artificial intelligence in headache care.

Nature reviews. Neurology·2026
Same journal

Artificial intelligence could reshape research and care in disorders of consciousness.

Nature reviews. Neurology·2026
Same journal

Christina Kim: functional and biochemical mapping of neural circuits.

Nature reviews. Neurology·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.7K

The multiple sclerosis prodrome.

Naila Makhani1, Helen Tremlett2

  • 1Departments of Pediatrics and of Neurology, Yale School of Medicine, New Haven, CT, USA.

Nature Reviews. Neurology
|June 22, 2021
PubMed
Summary
This summary is machine-generated.

The prodrome, or early signs preceding disease onset, is gaining attention in multiple sclerosis (MS). Understanding the MS prodrome could lead to earlier diagnosis and treatment, improving patient outcomes.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Related Experiment Videos

Last Updated: Nov 1, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.7K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.9K
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Area of Science:

  • Neurology
  • Immunology

Background:

  • Prodromal phases are recognized in many neurological and inflammatory diseases.
  • The prodrome of multiple sclerosis (MS) has historically received limited research focus.
  • Recent years have seen increased interest in the potential for an MS prodrome.

Purpose of the Study:

  • To summarize current knowledge regarding the prodrome in multiple sclerosis (MS).
  • To explore the potential duration, clinical manifestations, and biomarkers of the MS prodrome.
  • To draw parallels from prodromal research in other diseases to inform MS understanding.

Main Methods:

  • Literature review and synthesis of existing research on MS prodrome.
  • Comparative analysis of prodromal phases in other neurological and inflammatory conditions.
  • Identification of knowledge gaps and future research directions.

Main Results:

  • The MS prodrome may encompass a range of early signs and symptoms preceding definitive MS diagnosis.
  • Potential biomarkers and clinical features of the MS prodrome are being investigated.
  • Insights from other diseases can guide MS prodrome research.

Conclusions:

  • Understanding the MS prodrome is crucial for earlier MS recognition and treatment initiation.
  • Earlier treatment can potentially reduce relapse rates and long-term disability in MS patients.
  • Re-evaluation of MS risk factors and causes is warranted in light of prodromal research.